Non-fungible tokens as a framework for sustainable innovation in pharmaceutical R&D: a smart contract-based platform for data sharing and rightsholder protection-Reference-Cited by-同舟云学术

Non-fungible tokens as a framework for sustainable innovation in pharmaceutical R&D: a smart contract-based platform for data sharing and rightsholder protection

Published:2023-07-20 Issue: Volume: Page:1-20
ISSN:1360-0869
Container-title:International Review of Law, Computers & Technology
language:en
Short-container-title:International Review of Law, Computers & Technology

Author:

Compagnucci Marcelo Corrales¹^ORCID,Nilsson Niclas²,Wagner Paul Stankovski³,Olsson Christoffer⁴,Fenwick Mark⁵,Minssen Timo¹,Szkalej Kacper⁶⁷

Affiliation:

1. Center for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen, Copenhagen, Denmark

2. LU Innovation, Lund University, Lund, Sweden

3. Department of Electrical and Information Technology, Faculty of Engineering (LTH), Lund University, Lund, Sweden

4. Xenit AB, Gothenburg, Sweden

5. Graduate School of Law, Kyushu University, Fukuoka, Japan

6. Center for Business Law (ACLU), Faculty of Law, Lund University, Lund, Sweden

7. Law and Informatics Research Institute (IRI), Faculty of Law, Stockholm University, Stockholm, Sweden

Funder

Novo Nordisk Foundation

Blockchain-powered open sharing platform for collaborative drug discovery

Publisher

Informa UK Limited

Subject

Law,Computer Science Applications

Link

https://www.tandfonline.com/doi/pdf/10.1080/13600869.2023.2233803

Reference47 articles.

1. An open source pharma roadmap

2. Sharing Research Data and Intellectual Property Law: A Primer

3. The Problem of Social Cost

4. “Commentary: The Coronavirus Pandemic Has Shattered the Status Quo on Drug Development. We Should Build on That | Fortune.” 2020. 2020. https://fortune.com/2020/03/26/coronavirus-vaccine-drug-development-open-science-covid-19-treatment/.